These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 11829698

  • 1. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
    Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T.
    JAMA; 2002 Feb 06; 287(5):598-605. PubMed ID: 11829698
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, randomized, controlled trial of the effects of two eggs per day in moderately hypercholesterolemic and combined hyperlipidemic subjects taught the NCEP step I diet.
    Knopp RH, Retzlaff BM, Walden CE, Dowdy AA, Tsunehara CH, Austin MA, Nguyen T.
    J Am Coll Nutr; 1997 Dec 06; 16(6):551-61. PubMed ID: 9430083
    [Abstract] [Full Text] [Related]

  • 3. Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry.
    Beauchesne-Rondeau E, Gascon A, Bergeron J, Jacques H.
    Am J Clin Nutr; 2003 Mar 06; 77(3):587-93. PubMed ID: 12600847
    [Abstract] [Full Text] [Related]

  • 4. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.
    Sweany AE, Shapiro DR, Tate AC, Goldberg RB, Stein EA.
    Clin Ther; 1995 Mar 06; 17(2):186-203. PubMed ID: 7614520
    [Abstract] [Full Text] [Related]

  • 5. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G, Haraldsdottir SO, Melberg TH, Tikkanen MJ, Miettinen TE, Kristianson KJ.
    Acta Cardiol; 1998 Mar 06; 53(1):7-14. PubMed ID: 9638964
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults.
    Hodson L, Skeaff CM, Chisholm WA.
    Eur J Clin Nutr; 2001 Oct 06; 55(10):908-15. PubMed ID: 11593354
    [Abstract] [Full Text] [Related]

  • 9. Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.
    Mitropoulos KA, Armitage JM, Collins R, Meade TW, Reeves BE, Wallendszus KR, Wilson SS, Lawson A, Peto R.
    Eur Heart J; 1997 Feb 06; 18(2):235-41. PubMed ID: 9043839
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D, Morgan C, Rigby RJ, Westhuyzen J.
    Am J Kidney Dis; 2002 Feb 06; 39(2):283-90. PubMed ID: 11840368
    [Abstract] [Full Text] [Related]

  • 11. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.
    Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O.
    Diabetes Care; 1997 May 06; 20(5):881-7. PubMed ID: 9135961
    [Abstract] [Full Text] [Related]

  • 12. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
    Zambón D, Sabaté J, Muñoz S, Campero B, Casals E, Merlos M, Laguna JC, Ros E.
    Ann Intern Med; 2000 Apr 04; 132(7):538-46. PubMed ID: 10744590
    [Abstract] [Full Text] [Related]

  • 13. Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
    Farrer M, Winocour PH, Evans K, Neil HA, Laker MF, Kesteven P, Alberti KG.
    Diabetes Res Clin Pract; 1994 Mar 04; 23(2):111-9. PubMed ID: 8070302
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients.
    Szkodziński J, Romanowski W, Hudzik B, Kaszuba A, Nowakowska-Zajdel E, Szkilnik R, Pietrasińska B, Zubelewicz-Szkodzińska B.
    Pharmacol Rep; 2009 Mar 04; 61(4):654-64. PubMed ID: 19815947
    [Abstract] [Full Text] [Related]

  • 17. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.
    De Caterina R, Cipollone F, Filardo FP, Zimarino M, Bernini W, Lazzerini G, Bucciarelli T, Falco A, Marchesani P, Muraro R, Mezzetti A, Ciabattoni G.
    Circulation; 2002 Nov 12; 106(20):2543-9. PubMed ID: 12427649
    [Abstract] [Full Text] [Related]

  • 18. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial.
    Ros E, Núñez I, Pérez-Heras A, Serra M, Gilabert R, Casals E, Deulofeu R.
    Circulation; 2004 Apr 06; 109(13):1609-14. PubMed ID: 15037535
    [Abstract] [Full Text] [Related]

  • 19. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
    Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD.
    Metabolism; 2000 Sep 06; 49(9):1234-8. PubMed ID: 11016911
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.